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Abstract
Background: A number of studies suggest females may be more likely to engage in injection and sex risk
behavior than males. Most data on gender differences come from industrialized countries, so data are needed in
developing countries to determine how well gender differences generalize to these understudied regions.
Methods: Between 1999 and 2003, 2512 male and 672 female current injection drug users (IDUs) were surveyed
in ten sites in developing countries around the world (Nairobi, Beijing, Hanoi, Kharkiv, Minsk, St. Petersburg,
Bogotá, Gran Rosario, Rio, and Santos). The survey included a variety of questions about demographics, injecting
practices and sexual behavior.
Results: Females were more likely to engage in risk behaviors in the context of a sexual relationship with a
primary partner while males were more likely to engage in risk behaviors in the context of close friendships and
casual sexual relationships. After controlling for injection frequency, and years injecting, these gender differences
were fairly consistent across sites.
Conclusion: Gender differences in risk depend on the relational contexts in which risk behaviors occur. The fact
that female and male risk behavior often occurs in different relational contexts suggests that different kinds of
prevention interventions which are sensitive to these contexts may be necessary.
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Background
Female injection drug users (IDUs) frequently have been
found to engage in more risk behavior than males. For
example, in a general sample of drug users in Denver,
Colorado, Booth [1] found that needle sharing was more
common among females than males. Among IDUs in
England, receptive sharing of needles and syringes was
more common among females than males [2]. Among
IDUs not in treatment in Paterson, New Jersey, recent
injecting with a sex partner was more common among
females [3], and this was often an injection given to the
female by the male after the male had already injected.
Both receptive and distributive injection equipment shar-
ing were more common among female than male IDUs in
Toronto [4].
Females IDUs in Marseille, France were both less likely to
clean used needles and less likely to use condoms with a
primary sex partner than males [5]. Johnson and col-
leagues found more needle sharing among female IDUs,
and suggested this might have been due to higher depres-
sion among females, since females were more depressed
and depression was related to needle sharing [6]. Also,
data collected as part of the NIDA Cooperative Agreement
for AIDS Community-Based Outreach/Intervention
Research showed that needle sharing was more frequent
among female than male IDUs, and this effect was consist-
ent across the 18 sites studied [7]. There are a number of
reasons why female IDUs may engage in more risk behav-
ior. Females may be more stigmatized for their drug use,
and stigmatization may lead to more risk behavior. For
example, women may avoid using syringe exchanges out
of fear that they will be recognized within their commu-
nity as an injection drug user, leading to eviction or loss of
child custody [8].
Although there are plausible reasons for gender differ-
ences in injection risk behavior and differences frequently
are observed, some studies have failed to find increased
risk behavior among female IDUs [9]. For example, Rieh-
man and colleagues [10] found no gender differences in
receptive or distributive syringe sharing among California
IDUs presenting at syringe exchanges. Also, female and
male drug users treated in a New York City emergency
department were found to have similar rates of HIV risk
behavior [11]. There is also evidence of both more risky
and more protective behavior among females; for exam-
ple, Montgomery and colleagues reported that female
IDUs shared needles more frequently, but were more
likely to use needle exchange and carry clean syringes than
male IDUs [12].
The fact that studies have not always found that female
IDUs are more risky may be due in part to males and
females engaging in different types of risk behavior
[5,13,14]. For example, Bennett and colleagues [2] found
that male injectors engaged in more distributive sharing
of equipment other than syringes while females recep-
tively shared injection equipment more often. In addition
to engaging in different types of risk behavior, female and
male IDUs may share syringes and other injection equip-
ment with different types of people. Valente and Vlahov
[15] showed that injection risk behavior is often selective,
in that it occurs in the context of close personal ties
between sexual partners or among a network of injectors.
When female IDUs are found to engage in more risk
behavior, this may be selective risk behavior that often
occurs in the context of a primary sexual relationship
[1,3,5,13,16-20]. Female IDUs are more likely to have
injecting sex partners than male IDUs [3,17], and this dif-
ference may provide more opportunities for female IDUs
to selectively engage in injection equipment sharing with
those sex partners. This is consistent with findings of a sur-
vey of San Francisco IDUs [21], where female IDUs were
more likely than males to have borrowed needles and
other injection equipment in the past 3 months. Females
also were more likely to have been injected by someone
else. But it was much more common for female rather
than male IDUs to have injected with a sex partner, and
females were more likely to borrow needles from a sex
partner. Importantly, the relation between gender and
both needle sharing and other injection equipment shar-
ing was no longer significant once injecting with a sex
partner was controlled. While the relation between female
gender and being injected by someone else persisted after
controlling for injecting with a sex partner, on the whole
the results suggest that a good deal of female injection risk
behavior occurs in the context of sexual relationships.
Although most data on gender differences in risk behavior
among IDUs come from industrialized countries, a couple
of recent studies have reported on gender differences in
developing countries. One study conducted in Sichuan
Province, China [22] found that female and male IDUs
were equally likely to have injected with a used needle
from a sex partner in the past year. Receptive needle shar-
ing with friends, sharing other injection equipment, and
unprotected sex with primary and casual partners were
also found to be similar among female and male IDUs.
Differences did emerge on one injection risk behavior,
using needles prepared by other people, but male IDUs
were more likely than female IDUs to report this behavior.
Among young injectors in St. Petersburg, Russia, female
IDUs engaged in more sexual risk behavior than male
IDUs [23], but it was not clear how much of that differ-
ence was due to sex work being more common among
females. Also, females and males both shared injection
equipment about four and a half times in the past month,
with no significant gender difference [24]. However, the
females in this study were more likely than the males toBMC Public Health 2007, 7:271 http://www.biomedcentral.com/1471-2458/7/271
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report being injected by someone else. The sample in
Sichuan was much older than the sample in St. Petersburg
and one study asked about risk behavior in the past year
while the other asked about the past month; despite these
differences, neither study found the expected relation
between female gender and the sharing of injection equip-
ment. Thus, these two studies raise the possibility that
gender differences that have been found frequently in
industrialized countries might not be observed consist-
ently in developing countries.
The purpose of this paper is to examine the consistency of
gender effects on injection risk behaviors across multiple
sites in developing and transitional countries. Regardless
of whether effects are found or not, or suggest males or
females are more risky, findings which are consistent
across multiple sites are highlighted and contrasted with
inconsistent sites.
Methods
As part of the overall WHO Drug Injection Study Phase II,
a cross-sectional seroprevalence and risk behavior survey
of injecting drug users was carried out in various cities
from mid 1999 through 2003 (see [25] and [26] for a full
description of the study). The survey was conducted at dif-
ferent times in each city and data collection typically
lasted 6 to 9 months or longer. Centralized survey coordi-
nation, including creation of a core questionnaire with
additional optional sections, preparation of guidelines for
local survey operations, technical support, and compila-
tion of data into a master database, facilitated local ques-
tionnaire modification within the core structure,
standardized data collection protocols, and uniform data-
base structure. Following the guidelines, each site was
required to plan the local survey operations, adapt and
translate the prototype questionnaire for local use, hire
and train fieldworkers, pilot the questionnaire, identify
recruitment locations, develop local sampling/recruit-
ment protocols, select laboratory facilities and arrange for
HIV serotesting, recruit and interview subjects, and enter
questionnaire data into a computer database. Each partic-
ipating site assumed responsibility for the precise nature
and duration of training which typically lasted between
two and five days and covered all aspects of recruitment
and questionnaire administration, informed consent pro-
cedures, principles of communication with IDUs, safety
issues for field workers, record keeping, and data manage-
ment.
This report covers data collected from male and female
injecting drug users (IDUs) in 10 of the 12 cities which
participated in the survey including Nairobi (Kenya) in
Africa, Beijing (China) and Hanoi (Vietnam) in Asia,
Kharkiv (Ukraine), Minsk (Belarus) and St. Petersburg
(Russia) in Eastern Europe, and Bogotá (Colombia), Gran
Rosario (Argentina), Rio de Janeiro (Brazil) and Santos
(Brazil) in South America. In the remaining two cities,
Lagos (Nigeria) recruited very few female IDUs, and Pen-
ang (Malaysia) recruited none; thus adequate data on
female IDUs were unavailable in these cities.
Ethical review
Principal Investigators (PIs) and the Implementing Agen-
cies were required to adhere to the principles described in
the International Guidelines for Ethical Review of Epide-
miological Studies [27] as well as to any additional local
regulations, and to submit their entire study protocol for
review by a local Ethics Board to ensure that potential
risks of participant identification or loss of confidentiality
were minimized [25]. Each site was required to prepare an
informed consent information sheet clarifying possible
implications of study participation, to show (or read) to
participants, and to obtain written or verbal consent from
participants.
Confidentiality
In accordance with guidelines of the Department of Men-
tal Health and Substance Dependence, WHO (WHO/
MSB), potential risks to individual study recruits (e.g., risk
of violence, breach of law, loss of confidentiality, etc.) and
procedures for minimizing such risks were addressed in
the initial proposals submitted to WHO/MSB by individ-
ual site PIs and Implementing Agencies. In addition the
topic was covered in the Survey Operations Manual and
also fully discussed during a 4-day planning meeting in St.
Petersburg, Russia attended by the WHO/MSB project
team, the Coordinating Center teams, and representatives
from all participating cities except Nairobi (which had not
yet been selected at that time). Confidentiality issues cov-
ered the recruitment process, privacy during question-
naire administration, data storage, and linking of
laboratory data for the purposes of giving out test results.
However, since human subjects protection issues varied
across sites, the specific details of procedures for minimiz-
ing such risks were determined by individual PIs with
review and approval by local ethical review boards. More-
over, each participating site assumed responsibility for the
precise nature and duration of field worker training
including confidentiality issues. Data sets submitted to
the NYC Survey Coordinating Center (NYC-SCC) for anal-
ysis did not include any names.
Eligibility for survey enrollment
Recruitment of IDUs was restricted to those who had
injected during the 2 months prior to enrollment. Sub-
jects were recruited through community outreach in all
cities, and from drug treatment entrants in Asian and East-
ern European cities. Since most of the questionnaire sec-
tions on drug use and risk behaviors covered the 6-month
period preceding study enrollment, recruitment fromBMC Public Health 2007, 7:271 http://www.biomedcentral.com/1471-2458/7/271
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treatment settings was limited to clients newly-admitted
to a treatment program (within the past 30 days), since
such clients could be considered to have been 'part of the
community' for most of the six-month period. Apart from
the current course of treatment, the subject should not
have been in that same treatment program or any other
treatment program during the preceding 6 months. Com-
munity recruits were drawn from any non-treatment set-
tings, preferably from street locations. If a person
recruited from a community setting was currently attend-
ing drug treatment this did not render him/her ineligible
as a community recruit.
Sampling procedures and recruitment of subjects
Owing to the vastly different situations across cities, a
completely uniform approach to sampling and recruit-
ment was not considered feasible. Overall guidelines were
provided, but the ultimate decision on design and imple-
mentation of local sampling and recruitment protocols
was made by each site investigator in consultation with
the survey coordinators. For treatment recruitment, where
random selection was not feasible (due primarily to small
numbers of incoming patients), sequential new admits
were screened for eligibility and all meeting the criteria
were invited to participate in the survey. Since random
selection of subjects in the community was typically not
feasible, techniques such as peer-referral, snowball sam-
pling, and targeted sampling, were used in order to access
the hidden populations. Investigators were asked to make
every effort to obtain a diverse sample of the non-treat-
ment population in the area.
Persons recruited from drug treatment facilities were usu-
ally interviewed in a specially assigned room inside the
facility where recruitment took place. On the other hand,
community recruits were typically recruited in one loca-
tion but interviewed in private rooms elsewhere. The vari-
ety of interviewing venues included rooms in lodging
houses or a church hall in Nairobi, confidential locations
chosen by participants in Beijing, commune health cent-
ers in Hanoi, the Regional AIDS Centre in Kharkiv, the
Narcological Dispensary, National Center for AIDS Pre-
vention or the Syringe Exchange Outlet in Minsk, a bus
(small van) which traveled to selected locations in St.
Petersburg, and private offices in cooperating NGOs in
Bogotá. Locations were often chosen to minimize visibil-
ity to citizens and police or even to protect the field staff
from violence from other drug users. In some cases inter-
views had to be conducted in more public places such as
cafes, discos, etc. but every attempt was made to maintain
confidentiality.
In Beijing and Nairobi, monetary incentives were offered
for survey participation, and in Hanoi, Bogotá and Rio de
Janeiro participants' transportation expenses were paid by
the project. Additionally, in Beijing, Hanoi and Bogotá,
incentives were given to recruits to refer other drug users
to the study. For the community sample, rates of refusal to
participate in the study were reported by only three of the
sites. In Kharkiv 3%–5% of eligible recruits refused to be
interviewed. Reasons include anxiety about being identi-
fied or "registered" as a drug addict, no interest in the
study, or poor state of health. The 9% refusal rate in St.
Petersburg appeared to be primarily due to the length of
the questionnaire. In Bogotá, 30% of persons contacted
did not keep their appointments, and although specific
reasons for refusal were not always available, some of the
drug users reported fear of receiving a positive blood test
result, dread of the phlebotomy procedure, or apprehen-
sion of identification during the procedure. Additionally,
the Nairobi team reported that the refusal rate appeared to
be "very low", mostly from persons who felt that the mon-
etary incentive was insufficient, and the Minsk team
reported that most of the approached IDUs agreed to par-
ticipate in the study. No information was received for the
remaining sites. Although specific refusal rates among
drug treatment entrants were not reported by any of the
sites, the overall impression was that persons in drug treat-
ment were less likely to refuse because they were already
openly identified as drug users. In particular, the Minsk
report indicated that participation in the study provided a
welcome change in the everyday routine activities in the
treatment center.
Questionnaire
Although sites were permitted some flexibility to include
questions of local interest only, the core part of the struc-
tured questionnaire comprised questions to be asked at all
study sites.
Translation of the questionnaire was carried out locally at
each site – into Mandarin in Beijing, Vietnamese in
Hanoi, Spanish in Bogotá and Gran Rosario, and Portu-
guese in Rio de Janeiro and Santos. The three Eastern
European countries collaborated on translation into Rus-
sian. Unfortunately, limited resources precluded back-
translation. In Nairobi, the English version was used. The
locally-adapted structured questionnaire was adminis-
tered by a trained interviewer to each eligible recruit.
Only two sites reported the questionnaire administration
time. In Beijing it was about 30 minutes, whereas Minsk
reported between 1 hour 30 minutes and 1 hour 50 min-
utes. However, Beijing had shortened the local version of
the questionnaire based on rapid assessment findings and
used almost none of the optional sections whereas the
Minsk questionnaire included some of the longer local
option sections. Both the Kharkiv and St. Petersburg
teams indicated that the questionnaire appeared overly
long. Survey questions were necessarily translated forBMC Public Health 2007, 7:271 http://www.biomedcentral.com/1471-2458/7/271
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administration at each study site, and the description of
measures below presents the English versions of each
question.
Measures
Daily injection
IDUs were asked how often during the past 6 months they
injected speedball, heroin alone, cocaine alone, metham-
phetamines, or any other substance injected locally. Pos-
sible responses included the following: "Never"; "Less
than once a month"; "1 to 3 times a month"; "About once
a week"; "2 to 3 times a week"; "4 to 6 times a week";
"About once a day"; "2–3 times a day, almost every day";
and "4 or more times a day, almost every day". If daily or
more frequent injecting was indicated for any injected
substance, then the IDU was considered a daily injector.
Years injecting
This was determined by subtracting age of first injection
from age at interview. This difference was then subjected
to a natural logarithm transformation for generalized lin-
ear models.
Sex work
IDUs were asked, "In the last 6 months how often have
you had a client who gave you money or goods for sex?"
and "In the last 6 months how often have you had a client
who gave you drugs for sex?" If responses indicated sex
work for money, goods, or drugs with any frequency, then
the IDU was considered a sex worker. Male IDUs in the
Hanoi site were not asked these two questions, so sex
worker status was missing.
Risk behaviors
Survey items asked about the following twelve risk behav-
iors: receptive syringe sharing (i.e., receiving a used nee-
dle/syringe from another IDU); distributive syringe
sharing (i.e., passing on a used needle/syringe to another
IDU); cooker/cotton/rinse water sharing; drawing from a
common drug solution; injecting with a pre-filled syringe;
frontloading/backloading/splitting; receptive sharing
with a primary sex partner; receptive sharing with a close
friend; distributive sharing with a primary sex partner; dis-
tributive sharing with a close friend; unprotected sex with
a primary sex partner; unprotected sex with a casual sex
partner. IDUs were asked how often in the last 6 months
they had engaged in each risk behavior, and these fre-
quencies were then recoded to indicate simply whether or
not that the behavior occurred. IDUs in Beijing were not
asked about distributive sharing with primary sex partners
and with close friends, so this site could not be included
in any analyses of those two risk behaviors.
Analysis
Site-specific bivariate analyses of demographic and other
characteristics were undertaken to better understand gen-
der differences. Differences between males and females
were tested for significance with t-tests for continuous var-
iables and Chi-squared tests for categorical variables.
Each of the twelve risk behaviors was examined sepa-
rately. As a first step, site-specific logistic regression mod-
els were fit to determine the effect of female gender on a
specific risk behavior within each site. Daily injection and
years injecting were included as covariates in each of the
site-specific models because bivariate analyses showed
that daily injection was significantly related to all twelve
of the risk behaviors and years injecting was significantly
related to ten of the risk behaviors.
Next, multi-site models were used to assess the consist-
ency of gender effects across sites, and to identify individ-
ual sites in which the gender effect differed from other
sites in size or direction. The initial models were fit with
main effects for site, gender, daily injection, and years
injecting, and two-way interactions between site and each
of the other three main effect variables. For each behavior,
the initial model was simplified by removing two-way
interaction terms if that removal improved the Akaike
Information Criterion (AIC [28]). If the site by gender
interaction effect was retained, this indicated that gender
effects were inconsistent across sites, while removal of the
site by gender interaction effect indicated that any appar-
ent inconsistencies across sites were merely due to sam-
pling variation. If the site by gender interaction term was
removed, the resulting multi-site model provided a single
overall estimate of the gender effect across sites control-
ling for differences in site, daily injection, and years inject-
ing.
For risk behaviors in which a site by gender interaction
effect remained, we determined the most inconsistent site
by examination of the adjusted odds ratios in Figure 1,
then re-applied the AIC criterion to a model without the
inconsistent site. This process was repeated until we
arrived at a model with no site by gender interaction effect
to provide an estimate of the overall gender effect for the
set of consistent sites. Adjusted odds ratios for the incon-
sistent or outlying sites were obtained from the site-spe-
cific models described earlier.
Statistical significance was evaluated using 2-sided tests
and an alpha level of .05 throughout.
Results
Gender differences within each site are presented for
demographics and other key variables (Table 1). Overall,
females tended to be slightly younger than males, to haveBMC Public Health 2007, 7:271 http://www.biomedcentral.com/1471-2458/7/271
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similar levels of education, and were more likely to be
married. However, in Hanoi and Nairobi, where the
majority of female IDUs were sex workers, females were
less likely to be married than males. Sex work was far
more common among females than males and at least
25% of females in Nairobi, Hanoi, St. Petersburg, Rio de
Janeiro and Santos reported sex with clients. Females were
less likely to derive their main income from legal employ-
ment. Overall, female IDUs were more likely to be new
injectors with shorter injection careers. Apart from a cou-
ple of isolated cases, heroin or cocaine use did not differ
by gender, but IDUs in south American cities clearly
favored cocaine, whereas heroin was the primary injection
drug in most of the remaining cities. Gender differences
on injection frequency were inconsistent, with daily injec-
tion occurring more among females in Hanoi, St. Peters-
burg, and Santos but more among males in Kharkiv.
However, it is notable that injection frequency in the
"cocaine" sites was considerably lower than elsewhere for
both males and females.
Table 2 presents summaries of risk behaviors by site. It is
important to note the considerable variability in these risk
behaviors across study sites. For example, only 19% of
IDUs in Hanoi had engaged in receptive syringe sharing in
the past 6 months, while more than half (54%) of St.
Petersburg IDUs did so. These site differences are taken
into account when examining gender differences in the
multisite models described below. The consistency of any
Adjusted Effect of Female Gender on Injection Risk Figure 1
Adjusted Effect of Female Gender on Injection Risk. 95% confidence intervals for adjusted odds ratios by site and type 
of risk.
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Table 1: Demographic and injection drug use characteristics
Age 12 or More Years 
Education
Currently Married Any Sex with Clients Main Source of 
Income Legal Work
Female N Male N Female Mean (SD) Male Mean (SD) Female % Male % Female % Male % Female % Male % Female % Male %
Africa Nairobi 14 92 28 (8) 29 (7) 7 25 0 23* 86 2* 21 67*
Asia Beijing 88 278 28 (6) 31 (7)* 26 10* 47 38 3 <1* 26 59*
Hanoi 119 526 25 (5) 29 (7)* 20 24 11 29* 77 - 13 63*
Eastern Kharkiv 112 326 24 (5) 25 (6) 38 28* 35 28 7 <1* 59 64
Europe Minsk 91 309 23 (5) 24 (5)* 62 51 37 23* 3 1 36 57*
St. Petersburg 103 297 23 (5) 24 (4) 45 45 34 24* 25 <1* 35 57*
South Bogota 49 188 23 (8) 23 (6) 20 22 29 13* 8 1* 12 27*
America Gran Rosario 68 261 29 (8) 28 (8) 18 10 48 34* 19 3* 43 43
Rio de Janeiro 12 177 29 (10) 29 (10) 25 14 42 24 25 17 33 77*
Santos 16 58 30 (7) 33 (9) 0 2 38 28 44 14* 31 72*
Africa Nairobi 14 92 5 (4) 6 (3) 57 27* 93 92 100 99 0 2
Asia Beijing 88 278 2 (2) 2 (3) 81 74 95 92 93 96 0 1
Hanoi 119 526 2 (3) 3 (4)* 76 70 97 83* 94 95 - -
Eastern Kharkiv 112 326 5 (4) 6 (5) 46 35* 50 70* 9 21* 4 4
Europe Minsk 91 309 4 (3) 5 (4)* 53 46 57 59 79 86 10 8
St. Petersburg 103 297 5 (5) 5 (4) 45 37 92 84* 94 92 2 4
S o u t h B o g o t a 4 9 1 8 8 4  ( 5 ) 5  ( 5 ) 6 36 0 4 2 1 42 21 4 5 1 *
A m e r i c a G r a n  R o s a r i o 6 8 2 6 1 1 1  ( 7 ) 1 0  ( 7 ) 1 32 21 51 5 1 2 9 79 3
R i o  d e  J a n e i r o 1 2 1 7 7 9  ( 9 ) 1 0  ( 9 ) 5 0 2 5 8583 1 0 0 9 8
Santos 16 58 9 (8) 12 (8) 19 12 44 19 6 3 100 100
Notes: * p < .05B
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Table 2: Risk behaviors by site
Nairobi 
(n = 106)
Beijing 
(n = 366)
Hanoi 
(n = 645)
Kharkiv 
(n = 438)
Minsk 
(n = 400)
St. Petersburg 
(n = 400)
Bogota 
(n = 237)
Gran Rosario 
(n = 329)
Rio de Janeiro 
(n = 189)
Santos 
(n = 74)
Receptive Sharing 28 27 19 52 30 54 47 23 36 22
Distributive Sharing 44 22 9 47 32 65 44 16 39 15
Cooker/Cotton/RinseWater 
Sharing
4 0 1 6 9 2 8 5 98 16 83 0 4 8 4 3
Drawing From a Common 
Solution
18 20 14 82 68 80 67 27 63 32
Pre-Filled Syringe 3 1 11 61 26 6 3 20 32 18
Frontloading/Backloading/
Splitting
14 9 14 23 25 69 2 13 17 8
Receptive Sharing Primary Sex 
Partner
6 3 3 1 6 71 568 37
Receptive Sharing Close Friend 22 23 14 39 23 36 34 18 26 15
Distributive Sharing Primary 
Sex Partner
5-1 1 6 8 1 7 5 5 8 3
Distributive Sharing Close 
Friend
42 - 5 37 20 40 37 13 26 8
Unprotected Sex Primary 
Partners
39 47 40 83 58 38 58 50 53 51
Unprotected Sex Casual 
Partners
71 052 7 2 0 1 2 2 7 2 5 5 0 1 8
Notes: Cell contents are the percentage of IDUs engaging in the risk behavior in the past 6 months. IDUs in Beijing were not asked about distributive sharing with primary sex 
partners and close friends. Missing data for other sites and behaviors ranged from 0–10% but was less than 1% in 75% of the 118 cells above.BMC Public Health 2007, 7:271 http://www.biomedcentral.com/1471-2458/7/271
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gender differences across sites also is a focus given the var-
iability across sites in the level of each risk behavior.
Figure 1 presents 95% confidence intervals around
adjusted odds ratios describing the effect of female gender
on each risk behavior within each site. The figure was con-
structed on the logit scale, but to facilitate interpretation
of female gender effect sizes, values were labeled with the
corresponding odds ratio. Each of these odds ratios are
adjusted for the effects of daily injection, and years inject-
ing. There were problems fitting these site-specific models
in two cases. In Beijing, only two IDUs injected with a pre-
filled syringe, and these were both males. In Santos, only
two IDUs engaged in distributive syringe sharing with a
primary sex partner, and these were both males. In both of
these cases, the odds ratio estimated for the adjusted gen-
der effect was very extreme and the standard error for the
gender coefficient also was quite large. Therefore, the
effects in these two cases were dropped from Figure 1.
Also, for the relevant risk behaviors, these sites were not
included in the multi-site models described below.
In the multisite analyses, for 6 of the 12 risk behaviors
considered there was no evidence of differential gender
effects across sites (Table 3). Overall, females were signif-
icantly more likely to engage in frontloading/backload-
ing/splitting, distributive syringe sharing with a primary
sex partner, and unprotected sex with a primary sex part-
ner. On the other hand, there were no significant gender
effects on receptive syringe sharing, distributive syringe
sharing, and drawing from a common drug solution.
For each of the remaining six risk behaviors, the gender
effect in one or more sites diverged significantly from the
other sites. Across all sites except for Minsk females were
significantly more likely to engage in cooker, cotton, and
rinse water sharing, whereas in Minsk females were signif-
icantly less likely to engage in this risk behavior. With the
exception of IDUs in Kharkiv females were more likely to
inject with a prefilled-syringe, but in Kharkiv the opposite
was true. Although females were significantly more likely
to engage in receptive syringe sharing with a primary sex
partner in all sites, the gender effect was significantly
stronger in Hanoi than the other sites. On the other hand,
while females were significantly less likely to engage in
receptive syringe sharing with a close friend across all
sites, the gender difference was larger in Kharkiv than
other sites. Across seven of the sites females were signifi-
cantly less likely to engage in distributive syringe sharing
with a close friend, but in Nairobi and Bogotá females
were more likely to engage in this risk behavior. Finally,
across all sites except Hanoi, females were significantly
less likely to have unprotected sex with a casual partner,
but this was not true in Hanoi where females were more
likely to engage in the behavior.
Exploring the role of sex work
Female IDUs engage in sex work, often to support drug
use. Some have found sex work in females IDUs associ-
ated with more risk behavior [29,30] while others have
not [31]. Because apparent gender differences may be due
only to the fact that females are more likely to engage in
sex work, it is important to consider sex work when esti-
mating gender differences. As Table 1 shows, sex workers
of both genders were not consistently sampled across
sites. While this substantially limits our ability to control
for sex work, we tried to determine whether any of the
gender effects would change or need to be qualified if sex
work were included either as an additional covariate
where this was possible. When sex work was included as
Table 3: Adjusted effects of gender on risk behavior
Consistent Sites Inconsistent/outlying Sites Data not available
Receptive Sharing 1.14 (0.94 – 1.37) - -
Distributive Sharing 1.06 (0.87 – 1.30) - -
Cooker/Cotton/Rinse Water Sharing 1.79 (1.43 – 2.24) Minsk: 0.57 (0.35 – 0.91) -
Drawing From a Common Solution 1.15 (0.93 – 1.42) - -
Pre-Filled Syringe 1.58 (1.18 – 2.10) Kharkiv: 0.59 (0.38 – 0.93) Beijing
Frontloading/Backloading/Splitting 1.48 (1.17 – 1.85) - -
Receptive Sharing Primary Sex Partner 3.67 (2.74 – 4.91) Hanoi: 50.23 (12.67 – 351.20) -
Receptive Sharing Close Friend 0.78 (0.61 – 0.98) Kharkiv: 0.36 (0.21 – 0.59) -
Distributive Sharing Primary Sex Partner 2.62 (1.94 – 3.54) - Beijing and Santos
Distributive Sharing Close Friend 0.63 (0.48 – 0.82) Nairobi: 3.70 (1.06 – 15.36) Beijing
Bogota: 1.92 (1.00 – 3.70)
Unprotected Sex Primary Partners 1.67 (1.39 – 2.00) - -
Unprotected Sex Casual Partners 0.52 (0.39 – 0.69) Hanoi: 7.48 (3.61 – 16.01) -
Notes: Cell contents are adjusted odds ratios with 95% profile likelihood confidence intervals in parentheses. In Beijing, only two IDUs injected 
with a pre-filled syringe, and these were both males. In Santos, only 2 IDUs engaged in distributive syringe sharing with a primary sex partner, and 
these were both males. In both of these cases, the odds ratio estimated for the adjusted gender effect was very extreme and the standard error for 
the gender coefficient also was quite large. IDUs in Beijing were not asked about distributive sharing with primary sex partners and close friends.BMC Public Health 2007, 7:271 http://www.biomedcentral.com/1471-2458/7/271
Page 10 of 12
(page number not for citation purposes)
an additional covariate in the site-specific models
described above, the direction and significance of gender
effects were essentially the same. Another approach was to
confirm that the gender effects reported above were
observed among IDUs not engaging in sex work. This was
found to be the case, as gender effects in the total sample
were also very similar in pattern to gender effects within
the subgroup of IDUs who had not engaged in sex work.
Discussion
Summary of findings
A relatively consistent pattern of gender differences
emerged. Females were more likely than males to engage
in injection and sex risk behavior with primary sex part-
ners. Males were more likely than females to engage in
injection risk behavior with close friends and to engage in
sex risk behavior with casual partners, and this was largely
consistent across sites. There was a consistent lack of gen-
der differences on several risk variables that did not spec-
ify the relational context of the risk behavior (receptive
syringe sharing, distributive syringe sharing, and drawing
from a common drug solution).
Overall, gender differences were found when the rela-
tional context of the risk behavior was specified, but males
and females were similar when the questions asked about
risk in general and no context was specified. There were
some exceptions to this overall pattern. Females were con-
sistently more likely to frontload, backload or split. In
sites other than Kharkiv, females were more likely to inject
with a pre-filled syringe. Also, females in sites other than
Minsk were more likely to share cookers, cotton, or rinse
water. In each of these cases, gender differences were
smaller in size than for the behaviors for which relational
context was specified.
Female IDUs were much more likely to engage in sex
work. When sex work was added as a covariate, this did
not change the basic pattern of gender differences. Also,
the pattern of gender effects observed in the total sample
was quite consistent with the pattern observed only
among IDUs not engaging in sex work. This suggests that
the current pattern of gender effects may generalize fairly
well to other samples of IDUs who are not engaged in sex
work. Because sex workers of both genders were not con-
sistently sampled across the sites, the current sample's
ability to address gender effects among sex workers is far
more limited.
Implications
Prevention programs which take into account the inter-
personal/sexual relationships between female and male
IDUs are needed. There are a number of ways this could
be done. One approach is to highlight sexual relation-
ships as a salient context for injection risk behavior and
emphasize the avoidance of syringe sharing and other risk
behaviors with sexual partners. But it is not clear how fea-
sible that would be, particularly for IDUs in sexual rela-
tionships of longer duration. For couples who find it very
difficult to avoid sharing injection equipment, a better
prevention strategy might be to try to isolate the couple so
that neither partner engages in risk behavior outside of the
couple. Valente and Vlahov [15] noted the high rate of
turnover within IDU networks. Our current understand-
ing of the nature and duration of IDU sexual relationships
is very limited, and a better understanding is critical to
developing optimal and feasible approaches to preven-
tion. Prevention messages which focus on containing risk
behavior within a couple would be more effective if IDU
sexual relationships are longer-lasting but less effective if
these relationships are typically serially monogamous but
short-lived. These characteristics of IDU sexual relation-
ships may vary across contexts even though gender effects
are somewhat consistent.
There is a need for prevention programs to reach and work
with female IDUs. The drug and sex networks of females
may overlap more substantially than for males, possibly
making risk reduction more difficult [17].
Limitations
In several of the study sites, it was difficult to recruit
female IDUs for a variety of reasons [25], and several sites
remarked on the difficulty of recruiting female IDUs who
tended to be a more "hidden" group than male IDUs.
Even in cities where "official" data on drug users were
available there was no breakdown by mode of administra-
tion, thus it is not possible to obtain an accurate assess-
ment of the extent to which female IDUs were
undersampled. It also is not entirely clear how represent-
ative the sample in each site is of all male and female cur-
rent IDUs in those sites. In a few sites, females tended to
be younger, and this might partly account for differences
in risk. However, given that most respondents were in
their 20s or 30s, the size of the age differences between
males and females in each site did not seem large enough
to have an impact on injection risk behavior. There was
substantial variation in the proportion of females
included in the sample across sites. In sites with a small
number of female IDUs (Nairobi, Rio, and Santos), there
is a great deal more uncertainty in the size of gender dif-
ferences than in sites with a substantial number of
females. There was also substantial variation in the pro-
portion of females engaging in sex work across cities. In
sites with few or no sex workers in the sample, there is a
great deal of uncertainty in the effect of sex work on risk,
and that partly carries over to uncertainty about gender
differences.BMC Public Health 2007, 7:271 http://www.biomedcentral.com/1471-2458/7/271
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The proportion of females recruited in each site was not
necessarily reflective of the population proportion, and
was based largely on specific sampling approaches in each
site. For example, in Hanoi, recruitment was undertaken
at a rehabilitation center for female sex workers (FSW)
since it was known that there was a high prevalence of
IDU among FSW. In other sites such as Kharkiv and
Minsk, the sample proportion of females is consistent
with local estimates of the proportion of female IDUs in
the population. In the limited information on refusal to
participate available from five of the ten sites, there was
no indication of differential refusal by gender.
Finally, all data were obtained by self-report, which may
be subject to poor memory or deception. Also, the data
come from straightforward survey items with excellent
face validity, but no other information on the validity or
reliability of the items has been presented.
Conclusion
Surveys of male and female IDUs in additional locations
are needed to continue to explore the degree to which gen-
der differences generalize across a variety of regions and
local circumstances. When investigating gender differ-
ences in risk, it is important to ask about the context of the
behavior in addition to the amount. It is important to
control for other factors related to risk behavior in order
to isolate the effect of gender. More work is needed to
understand the duration and other features of the sexual
relationships of IDUs. In particular, it would be useful to
investigate how relationship features such as duration,
exclusivity, and embeddedness in wider IDU networks are
related to injection risk behavior.
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